Last $2.24 USD
Change Today +0.03 / 1.36%
Volume 33.1K
IMI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 1:04 PM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

intermolecular inc (IMI) Snapshot

Open
$2.20
Previous Close
$2.21
Day High
$2.28
Day Low
$2.20
52 Week High
10/23/13 - $6.41
52 Week Low
05/15/14 - $2.10
Market Cap
107.0M
Average Volume 10 Days
39.2K
EPS TTM
$-0.35
Shares Outstanding
47.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INTERMOLECULAR INC (IMI)

intermolecular inc (IMI) Related Bloomberg News

View More Bloomberg News

intermolecular inc (IMI) Related Businessweek News

No Related Businessweek News Found

intermolecular inc (IMI) Details

Intermolecular, Inc. develops and applies high productivity combinatorial (HPC) research and development technologies for the semiconductor and clean energy industries. Its HPC platform includes wet processing tools that apply HPC methods to fluids-based applications, such as cleans, deposition and wet etch, self-assembly, and surface treatment processes; and dry processing tools, which apply HPC methods to vapor-based applications for primary, secondary, and tertiary screening. The company’s HPC platform also comprise automated characterization systems to characterize the substrates processed by Tempus HPC processing tools and generates experimental data while matching processing throughput; and informatics software comprising workflow management software, analysis and reporting software, security and collaboration management software, and integration services. It serves semiconductor device, semiconductor materials and equipment, and clean-energy companies in the United States, Japan, Europe, the Middle East, and the APAC. The company was formerly known as The BEP Group, Inc. and changed its name to Intermolecular, Inc. in November 2004. Intermolecular, Inc. was founded in 2004 and is headquartered in San Jose, California.

253 Employees
Last Reported Date: 03/10/14
Founded in 2004

intermolecular inc (IMI) Top Compensated Officers

Co-Founder, Chief Executive Officer, Presiden...
Total Annual Compensation: $363.8K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $73.7K
Senior Vice President of Intellectual Propert...
Total Annual Compensation: $302.2K
Senior Vice President of Customer CDPs
Total Annual Compensation: $300.4K
Vice-President of Finance and Corporate Contr...
Total Annual Compensation: $239.6K
Compensation as of Fiscal Year 2013.

intermolecular inc (IMI) Key Developments

Intermolecular, Inc. Reports Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2014; Provides Earnings Guidance for the Third Quarter of 2014

Intermolecular, Inc. reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported total revenue of $9,934,000 compared to total revenues of $16,608,000 for the same period a year ago. Operating loss was $6,683,000 compared to $600,000 last year. Loss before income taxes was $6,857,000 compared to $744,000 last year. Net loss was $6,859,000 or $0.15 per basic and diluted share compared to $744,000 or $0.02 per basic and diluted share last year. Non-GAAP operating loss was $5,085,000 compared to Non-GAAP operating income of $764,000 last year. Non-GAAP net loss was $5,261,000 or $0.11 per diluted share compared to Non-GAAP net income of $620,000 or $0.01 per diluted share last year. Cash flows used in operations for the second quarter of 2014 were $1.4 million. The company invested $0.5 million in capital expenditures. For the six months, the company reported total revenue of $25,839,000 compared to total revenues of $34,041,000 for the same period a year ago. Operating loss was $10,331,000 compared to $1,811,000 last year. Loss before income taxes was $10,704,000 compared to $2,224,000 last year. Net loss was $10,710,000 or $0.23 per basic and diluted share compared to $2,230,000 or $0.05 per basic and diluted share last year. Net cash provided by operating activities was $659,000 compared to $10,065,000 last year. Purchase of property and equipment was $1,958,000 compared to $6,457,000 last year. Non-GAAP operating loss was $6,177,000 compared to Non-GAAP operating income of $953,000 last year. Non-GAAP net loss was $6,556,000 or $0.14 per diluted share compared to Non-GAAP net income of $534,000 or $0.01 per diluted share last year. For the third quarter of 2014, the company projects revenue in the range of $10 to $11 million. This revenue projection includes approximately $9.7 million from reported backlog as of June 30, 2014. Non-GAAP net loss, excluding stock-based compensation expense, is projected between a non-GAAP net loss of $5.0 million and $4.0 million, or between $0.10 per share to $0.08 per share.

Intermolecular, Inc. to Report Q2, 2014 Results on Aug 01, 2014

Intermolecular, Inc. announced that they will report Q2, 2014 results at 5:00 PM, Eastern Standard Time on Aug 01, 2014

Intermolecular, Inc., Q2 2014 Earnings Call, Aug 01, 2014

Intermolecular, Inc., Q2 2014 Earnings Call, Aug 01, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMI:US $2.24 USD +0.03

IMI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IMI.
View Industry Companies
 

Industry Analysis

IMI

Industry Average

Valuation IMI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book 1.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTERMOLECULAR INC, please visit www.intermolecular.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.